Skip to main content
Premium Trial:

Request an Annual Quote

Incyte, Baylor Announce Research Partnership

Premium

Incyte Genomics also said it had entered into a genomic research partnership with Baylor College of Medicine in Houston.

Under the terms of the agreement, scientists at Texas Children’s Cancer Center, a joint program of Baylor and Texas Children’s Hospital, will work with Incyte to conduct gene expression studies and determine the role of genes in the prevention, diagnosis, and treatment of cancers that commonly affect children.

Intellectual property resulting from this collaboration will be jointly owned by Baylor and Incyte and available for licensing through Incyte.

Incyte and Baylor scientists will design and conduct studies on gene and protein expression to examine the relationship of gene function to the progression and treatment of cancer.

Incyte will extract and analyze gene and protein expression data from Baylor’s biological samples for incorporation into the company’s LifeExpress gene expression database while Baylor will obtain access to Incyte’s LifeSeq Gold gene sequence database.

Filed under

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.